Back to Analysis

Boeing's China Order Doesn't Fix the Cash Flow Problem

A 200-plane Beijing commitment lifted the narrative, not the financials. Free cash flow has been negative in three of the last five years, capex has tripled since 2021, and the math still doesn't work at $240 per share.

May 15, 2026
10 min read

The Order Book Was Never the Problem

Boeing's stock fell on Friday despite a Trump-brokered headline that China would purchase more than 200 jets, with a possibility of expanding the deal to 750. The market did exactly the right thing. Boeing's problem has never been demand. It has been the company's ability to convert that demand into delivered aircraft, positive operating cash flow, and a balance sheet that can absorb the next inevitable shock.

The last five years tell the story in one line. Cumulative free cash flow from 2021 through 2025 is negative $14.0 billion. Cumulative net income over the same window is negative $20.9 billion. The 2025 result, a $2.23 billion profit on $89.5 billion of revenue, looks like the start of a recovery only if you ignore that free cash flow was still negative $1.9 billion and that capital expenditure has tripled from $980 million in 2021 to $2.94 billion last year. The plant needs more investment, not less. The supply chain needs more investment, not less. The certification queue needs more investment, not less.

The China announcement adds aircraft to the order book. It does not change the production cap, the supply chain bottlenecks at fuselage and engine suppliers, or the certification timeline on the 777-9. At today's $240 share price and a $180 billion market capitalisation, the market is paying 90 times trailing earnings for an aerospace business that has destroyed shareholder capital across the most recent industrial cycle. We are bearish at these levels and we will explain why in the rest of this piece.

Boeing Free Cash Flow by Year (USD Billions)

What Actually Happened on Friday

The sequence of Friday's events matters for understanding the equity reaction. Trump first announced that the US and China had reached a trade-related framework that included Beijing's commitment to purchase Boeing aircraft. The announced number was 200 jets, with optionality to expand to as many as 750 over a multi-year period. Then Trump disclosed personal Boeing stock holdings in his quarterly Q1 trade filing.

The market did not reward the announcement. Boeing closed lower on the day. By Monday, sell-side analysts had already moved past the order headline to focus on the actual delivery and production data. Several research notes pointed out that Boeing's monthly delivery cadence has not yet reached the rates necessary to convert the existing backlog within the contractually committed windows. Adding 200 future aircraft to a delivery system that is constrained does not accelerate cash conversion. It pushes the cash-flow recognition further into the future.

The specific cohort of aircraft tied to the China commitment matters too. China's prior preference has been for 737 MAX variants and the 787-9. Both lines are running at constrained rates. The MAX production is currently rate-limited by FAA-imposed quality oversight following the 2024 door plug incident. The 787 line has had its own tariff-related cost increases that compress per-unit margin. Adding Chinese delivery slots into either backlog does not relieve those constraints. It only converts political risk back into operational risk.

TickerXray Report

Run the full forensic analysis on Boeing

Get the complete Boeing report with all 12 quantitative models, AI-generated investment thesis, and real-time data.

12 forensic models
AI investment thesis
Manipulation detection
Expected return forecast

The Order-to-Cash Gap

Commercial aerospace economics work in cycles measured in decades, but cash flow is measured in quarters. Boeing's backlog problem has always been the gap between order intake and delivered revenue. When the production system functions, that gap converts. When it does not, the customer's deposit sits on the balance sheet as a liability and the company spends its own capital sustaining the supply chain that should have already paid for itself.

The 200-plane China commitment is a multi-year intake. Even at a heroic 50 deliveries per year, full conversion would extend past 2030. Boeing's 2025 commercial deliveries were still well below the pre-MAX-grounding peak. The 737 MAX line is recovering but is operating below its 38-per-month rate target, which is itself well below the planned 47-per-month profile management has guided to for 2027. The 787 line has had its own quality and tariff complications. The 777-9 has slipped certification windows three times, with the current target sitting in late 2026.

None of these constraints are made better by adding orders. Adding orders without adding production cadence creates one specific outcome: a longer backlog that customers price into delivery slot negotiations, applying downward pressure on margin. Airlines do not pay a premium for a slot they will not receive for five years. They use the gap as leverage on price, on configuration, and on customer-support concessions.

What the order does is buy political cover and a narrative anchor. The market reaction told you it priced both correctly. Shares fell on the news because nothing about the production environment changed. The fundamental question, which is when Boeing can sustainably generate $8-10 billion of annual free cash flow, was not answered by the announcement.

The Risk Desk view is direct. Boeing's recovery is a multi-year exercise in operating discipline, and the equity is being priced for a much faster turnaround than the manufacturing reality supports.

Capital Expenditure Trajectory (USD Billions)

Net Income Has Been Negative for Five of Six Years

The reported 2025 net income of $2.23 billion ended a four-year streak of losses, but the cumulative impact has already been absorbed by the balance sheet. Total debt sits at multi-decade highs relative to operating cash flow. Cash and equivalents finished 2025 at $10.9 billion, comfortable in absolute terms but thin against a debt stack approaching $50 billion when you add lease obligations and supplier financing.

The profit margin in 2025 was 2.46 percent. That is roughly one-third of the long-run aerospace margin Boeing earned in the pre-MAX era. Even a return to mid-cycle margins would imply a multi-quarter pricing reset on existing backlog and a sustained recovery in services margin, which has historically been the most reliable cash generator across the franchise.

Forward earnings expectations for 2026 imply a sharp acceleration. Consensus has earnings per share rising from approximately $3.10 to $9-11 next year. That implies operating cash flow expanding by $6-8 billion. Achievable, but only if delivery rates accelerate and 777-9 certification finally arrives. Either of those slipping by even one quarter materially compresses the bull case multiple.

The defence and space segment, which provides revenue stability through long-cycle government contracts, has its own margin challenges. Fixed-price development programs continue to absorb cost overruns that compress segment margin below mid-single digits. Until management resets the fixed-price book or renegotiates terms on the most exposed contracts, this segment is a drag on the consolidated cash flow profile rather than the stabiliser it should be.

Why The Multiple Is The Trade

The trade we keep coming back to is the multiple. At 90 times trailing earnings, the equity already prices a clean recovery. The bull case requires sustained execution. The bear case requires only normal aerospace execution risk. Asymmetry favours the bear.

Look at the historical cycle. In 2017, when Boeing was delivering record volumes and generating $13.6 billion of free cash flow, the equity traded at 24 times trailing earnings. The price then represented operational excellence backed by cash. The price now represents a partial recovery backed by debt. These are not comparable setups. They share a stock ticker. Nothing else.

The forward multiple of around 26 times next-year earnings only looks reasonable if you accept that 2026 earnings per share will land at the higher end of analyst estimates. The earnings revision risk into the next three quarters is, frankly, asymmetric to the downside. Suppliers are still rebuilding inventory positions after the 2024 strike. Engine availability for 737 production remains the single largest gating factor on delivery cadence. Customers are watching certification slippages and the related compensation packages with growing impatience.

The Risk Desk has held a bearish view on Boeing since the late 2024 cash flow print. The data has not changed the calculus. The China order changes the narrative for a news cycle. It does not change the income statement, the cash flow statement, or the production constraints.

Net Income by Year ($ Billions)

Airbus, Comac, and the Duopoly Question

The standard bull argument leans on the dual-source structure of commercial aerospace. There are only two large global OEMs. Airlines have to buy from one of them. That structural position protects pricing power and limits downside for both Boeing and Airbus.

The Risk Desk does not accept this framing without context. First, Airbus is taking market share. In every backlog measure that matters, Airbus has widened its lead since 2020. Order intake has been disproportionately tilted toward the A320neo family and the A350. Second, Comac is real. The C919 is now flying commercial routes in China. The 2026 production target for Comac sits around 70-90 aircraft, with internal Chinese carrier demand absorbing essentially the entire output. The structural position is not what it was a decade ago.

Third, the Trump-Xi negotiation matters more for what it implies about future deal flow than for the specific 200-plane number. China can switch suppliers if it chooses. Beijing has signalled that switching dynamically depending on trade negotiation outcomes is a viable lever. That undermines the long-run pricing power assumption baked into Boeing's terminal value.

The competitive position is weaker than the bull narrative implies, and the equity is not priced for that weaker position. That gap is the trade.

The Defence Segment Is Not the Hedge

Bulls often point to Boeing Defence, Space & Security as the natural hedge against commercial cyclicality. The pitch sounds clean: government contracts produce stable revenue, defence spending is rising globally, and Boeing has incumbent positions on multiple high-profile programs.

The data does not support the hedge thesis. The defence segment has been a margin liability for three consecutive years. Fixed-price development contracts on Air Force One, T-7A, KC-46, and MQ-25 have generated cumulative charges well in excess of $10 billion since 2018. These programs were bid at margins that did not adequately price the development risk. The result is a defence segment producing operating margins in the low single digits, well below the 10-12 percent range Lockheed and Northrop sustainably deliver.

The defence segment's revenue contribution to consolidated free cash flow is therefore minimal. Across the last five fiscal years, the segment has generated a near-zero net contribution to consolidated free cash flow after accounting for charges. That is not a hedge. That is a tax on the commercial segment until the fixed-price book ages out.

Management has indicated a policy of bidding new defence work only at cost-plus or risk-sharing terms. Sensible, but it takes years to age out a book of bad contracts. Until then, defence remains a drag rather than a counterweight.

Acknowledging the Bull Case and Why It Still Loses

The bull argument is straightforward. Order books at record highs, dual-source aerospace structure, China re-engagement, and operational leverage at the 737 line. If Boeing delivers 600 or more aircraft in 2026 and clears 777-9 certification, free cash flow could approach $5 billion. The narrative re-rates. The forward multiple could compress to a more reasonable 18-20 times earnings as the inflection becomes visible.

The Risk Desk rebuttal: every one of those conditions has been the consensus bull case for three consecutive years and none have materialised on schedule. The forward multiple is already pricing the recovery. Across three complete aerospace cycles, the pattern is consistent. Boeing trades at a peak multiple before the cash flow inflection, then the equity de-rates as the inflection slips by one or two quarters. The setup here looks identical to the 2023 and 2024 patterns that produced negative absolute returns over the subsequent twelve months.

The specific bull case risk that keeps showing up in the data is single-engine supplier dependency. CFM International, the GE-Safran joint venture, supplies the LEAP engines for the entire 737 MAX program. Any disruption at the engine supplier compresses Boeing's delivery rate one-for-one. There is no second source. The system has no redundancy. That is the fragility the bull case ignores.

Bearish at $240. The Catalyst Is the Cash Flow Print.

At a 90 times trailing P/E and an enterprise value approaching $230 billion, Boeing is being valued on a fully recovered operating profile. The recovery is real but it is not complete. Free cash flow has been negative for two of the last three years. Capex is climbing, not falling. The new China headline does not change the supply chain, certification, or production rate constraints that have defined the past six years.

We are bearish on Boeing at current levels. The Risk Desk price target sits in the $180-200 range based on a 14 times enterprise value to mid-cycle EBITDA framework once cash flow is firmly positive. That is roughly 17-25 percent below today's price.

The catalyst to revisit the thesis is a single quarter of positive free cash flow above $2 billion combined with confirmed 777-9 certification timing. Until both arrive, the equity is being priced ahead of the cash flow it has not yet generated. Historically, when aerospace primes have traded at multiples above 50 times trailing earnings during a delivery-rate ramp, the next 18 months have produced negative absolute returns roughly 70 percent of the time. The current setup does not look like the exception. It looks like the rule.

TickerXray Reports

Forensic-grade stock analysis, powered by AI

Every report runs 12 quantitative models and generates an AI investment thesis. From Piotroski scores to manipulation detection -- get the full picture in seconds.

12 forensic models

Piotroski, Altman, Beneish, DuPont & more

AI investment thesis

Synthesized outlook on every stock

Manipulation detection

Spot red flags before they hit the news

150,000+ tickers

Global coverage across 60+ exchanges

Expected return

Forward return projections for every stock

Real-time data

Live prices, insider trades, news sentiment

Free accounts get 1 report per month. Pro gets unlimited.